Celularity Inc (CELU) stock
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.48−0.09 (-15.41%)
Close on Nov 18, 2026Market cap $15.68MP/E –Yield –
Celularity shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Celularity's shares outstanding was 29M at Jun 30, 2026. For fiscal 2025 it was 26M, up 16.9% from the year before. The highest annual figure on record is 26M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26M | +16.9% |
| FY2024 | Dec 31, 2024 | 22M | +22.9% |
| FY2023 | Dec 31, 2023 | 18M | +18.9% |
| FY2022 | Dec 31, 2022 | 15M | +123.4% |
| FY2021 | Dec 31, 2021 | 7M | +264.1% |
| FY2020 | Dec 31, 2020 | 2M | -76.0% |
| FY2019 | Dec 31, 2019 | 8M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 29M | +22.2% |
| Q1 FY2026 | Mar 31, 2026 | 30M | +28.8% |
| Q4 FY2025 | Dec 31, 2025 | 28M | +27.6% |
| Q3 FY2025 | Sep 30, 2025 | 26M | +19.9% |
| Q2 FY2025 | Jun 30, 2025 | 24M | +9.9% |
| Q1 FY2025 | Mar 31, 2025 | 24M | +9.7% |
| Q4 FY2024 | Dec 31, 2024 | 22M | +16.2% |
| Q3 FY2024 | Sep 30, 2024 | 22M | +16.7% |
| Q2 FY2024 | Jun 30, 2024 | 22M | +23.7% |
| Q1 FY2024 | Mar 31, 2024 | 21M | +38.0% |
| Q4 FY2023 | Dec 31, 2023 | 19M | +3.2% |
| Q3 FY2023 | Sep 30, 2023 | 19M | +25.1% |
| Q2 FY2023 | Jun 30, 2023 | 18M | +16.7% |
| Q1 FY2023 | Mar 31, 2023 | 16M | +19.1% |
| Q4 FY2022 | Dec 31, 2022 | 19M | +49.9% |
| Q3 FY2022 | Sep 30, 2022 | 15M | +21.8% |
| Q2 FY2022 | Jun 30, 2022 | 15M | +530.7% |
| Q1 FY2022 | Mar 31, 2022 | 13M | +443.6% |
| Q4 FY2021 | Dec 31, 2021 | 12M | +572.8% |
| Q3 FY2021 | Sep 30, 2021 | 12M | +571.1% |
| Q2 FY2021 | Jun 30, 2021 | 2M | -8.0% |
| Q1 FY2021 | Mar 31, 2021 | 2M | -68.7% |
| Q4 FY2020 | Dec 31, 2020 | 2M | -28.9% |
| Q3 FY2020 | Sep 30, 2020 | 2M | -15.4% |
| Q2 FY2020 | Jun 30, 2020 | 3M | +15.9% |
| Q1 FY2020 | Mar 31, 2020 | 8M | – |
| Q3 FY2019 | Sep 30, 2019 | 3M | – |
| Q2 FY2019 | Jun 30, 2019 | 2M | – |
| Q1 FY2019 | Mar 31, 2019 | 2M | – |
See a number that looks wrong?